Thermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes

WALTHAM, Mass.–(BUSINESS WIRE)–Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”) announced today that it has priced an offering of €2.1 billion aggregate principal amount (the “Offering”) of the following euro-denominated notes, which will be issued by Thermo Fisher Scientific (Finance I) B.V., its indirect, wholly-owned finance subsidiary: €1,000,000,000 aggregate principal amount of its floating rate … [Read more…]

AHS Announces 2025 Scottsdale Headache Symposium® Featuring New Clinical Insights and Emerging Science in Headache Medicine

MOUNT ROYAL, N.J.–(BUSINESS WIRE)–#AHSAZ–The American Headache Society® (AHS), a professional society of healthcare providers dedicated to the study and treatment of headache and face pain, will host the 2025 Scottsdale Headache Symposium December 4-7 in Scottsdale, Arizona. This year’s meeting brings together physicians, scientists, and advanced practitioners for an immersive educational experience designed to elevate … [Read more…]

Phenindione (CAS 83-12-5) Industry Research Report 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 – Applications, Pricing, Manufacturers, End-Users, and Downstream Trends – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Phenindione (CAS 83-12-5) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. This report on Phenindione provides comprehensive insights, including general information, synonyms, chemical composition, safety, hazards, handling, storage, and toxicological and ecological details, along with transport information. This in-depth study serves … [Read more…]

How Elevance Health is Evolving the Healthcare Consumer Experience Through Improved Personalization and Higher Touch Service

Elevance Health is making healthcare more intuitive and personalized using technology to simplify access and build trust. Elevance Health’s affiliated health plans are building loyalty through connection and ongoing support. Digital tools address member pain points by providing clear, accurate, and personalized information. INDIANAPOLIS–(BUSINESS WIRE)–Saurabh Tandon, Elevance Health’s chief experience officer, shared his thoughts on … [Read more…]

Bristol Myers Squibb to Host Hematology-Focused Investor Event

PRINCETON, N.J.–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE: BMY) today announced that, following the conclusion of the American Society of Hematology (ASH) Annual Meeting and Exposition, the company will hold a virtual investor event on Thursday, December 11, 2025, to highlight key Hematology programs. The company will host a webcast beginning at 9:00 a.m. ET, which is … [Read more…]

POXEL SA: Update on the Proposed Recovery Plan and Organisation of a Webinar

Poxel’s recovery plan has been finalised: Main objectives: accelerating commercial development and partnership-seeking activities for Imeglimine outside Japan, PXL 770 and PXL 065, significantly reducing the Company’s costs, and clearing the Company’s liabilities. It was developed with the support of its long-standing financial partner IPF. IPF and IRIS have committed to providing the Company with … [Read more…]

Bayer’s Asundexian Met Primary Efficacy and Safety Endpoints in Landmark Phase III OCEANIC-STROKE Study in Secondary Stroke Prevention

Not intended for UK Media OCEANIC-STROKE demonstrates superiority of asundexian with antiplatelet therapy, showing significant reduction in ischemic stroke risk, without increasing ISTH major bleeding rate, compared to placebo with antiplatelet therapy OCEANIC-STROKE is the first successfully completed Phase III study of a Factor XIa inhibitor Bayer will globally engage with health authorities in preparation … [Read more…]

Transmural Systems Receives FDA 510(k) Clearance for Telltale

ANDOVER, Mass.–(BUSINESS WIRE)–Transmural Systems, a leader in pioneering electrosurgical structural heart therapies, obtained 510(k) clearance from the United States Food and Drug Administration (FDA) for TELLTALE – the first and only cleared and dedicated electrosurgical guidewire system to prevent coronary obstruction in patients undergoing Transcatheter Aortic Valve Replacement (TAVR) for both native aortic stenosis and … [Read more…]

ATCC Welcomes National Security Commission on Emerging Biotechnology for the Capital Region Stop of the Biotech Across America Roadshow

ATCC, industry, government, advocacy, and academic leaders met with NSCEB Commissioners for pivotal discussions on the critical role of authenticated biomaterials in a secure and resilient bioeconomy MANASSAS, Va.–(BUSINESS WIRE)–#Biomanufacturing—ATCC, the world’s premier private, non-profit biological resources and standards organization, hosted an event today, Empowering the Future of Biotechnology Through Trusted Science, with the National … [Read more…]